2026-10-11T14:45:01Z https://api.figshare.com/v2/oai

oai:figshare.com:article/20101109 2026-10-02T17:05:59Z category_7 category_13 category_14 category_19 category_46 category_64 category_106 category_132 category_134 portal_87 item_type_3 month_year_10_2026

RETRACTED ARTICLE: Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway Qi Wei (198826) Yuan Ren (149908) Xia Zheng (384416) Sufang Yang (305881) Tingting Lu (310355) Hongyao Ji (12895721) Haiqing Hua (396555) Kuizhong Shan (12895724) Medicine Genetics Molecular Biology Pharmacology Immunology Cancer Science Policy Infectious Diseases Virology target =' _blank akt signaling pathway x ., yang q ., ren h ., … publication .</ p decision .</ p article .</ p since publication ., zheng ., lu ., ji therefore retracting significant concerns scholarly record reported results remain online publishing ethics published work mediated glycolysis hepatocellular carcinomaprogression ginsenoside rg3 following article digitally watermarked bioengineered </ 2074616 </ 13 </ <p>We, the Editors and Publisher of the journal <i>Bioengineered</i>, have retracted the following article from publication.</p> <p>Wei, Q., Ren, Y., Zheng, X., Yang, S., Lu, T., Ji, H., … Shan, K. (2022). Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway. <i>Bioengineered</i>, <i>13</i>(5), 13919–13928. <a target="_blank" href="https://doi.org/10.1080/21655979.2022.2074616">https://doi.org/10.1080/21655979.2022.2074616</a></p> <p>Since publication, significant concerns have been raised about the integrity of the data and reported results in the article.</p> <p>When approached for an explanation, the authors have not responded to our queries and so these serious concerns remain unaddressed.</p> <p>As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The authors have been informed of this decision.</p> <p>We have been informed in our decision-making by our policy on publishing ethics and integrity and COPE guidelines.</p> <p>The retracted article will remain online to maintain the scholarly record and will be digitally watermarked on each page as ‘Retracted’.</p> 2022-06-20T07:20:04Z Dataset Dataset 10.6084/m9.figshare.20101109.v2 https://figshare.com/articles/dataset/Ginsenoside_Rg3_and_sorafenib_combination_therapy_relieves_the_hepatocellular_carcinomaprogression_through_regulating_the_HK2-mediated_glycolysis_and_PI3K_Akt_signaling_pathway/20101109 CC BY 4.0